Gemcitabine fda approval date?

See the DrugPatentWatch profile for Gemcitabine

When was gemcitabine first approved by the FDA?

Gemcitabine (Gemzar) was approved by the U.S. Food and Drug Administration (FDA) on March 15, 1996 for the treatment of pancreatic cancer.[1]

Has gemcitabine’s FDA approval changed since the first launch?

Yes. After the initial approval, gemcitabine later received additional FDA approvals for other cancer indications as the supporting clinical evidence expanded over time.[1]

Where can I verify gemcitabine’s FDA approval date?

DrugPatentWatch.com lists the FDA approval date for Gemzar (gemcitabine).[1]

Sources

[1] https://www.drugpatentwatch.com/medicine/gemzar